
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc. demonstrates a strong financial outlook, highlighted by a projected client count increase in 4Q25 and an expected adjusted operating income margin of approximately 22.4%, representing a substantial year-over-year improvement. The company exhibited impressive revenue growth of 53.3% and significant operating margin expansion, emphasizing effective marketing strategies and an innovative platform that enhances member engagement while driving yield improvements. With a current penetration rate of around 3.5%, significantly below traditional physical therapy rates, Hinge Health possesses considerable growth potential by leveraging tools like Hinge Connect to optimize client outreach and increase overall yields.
Bears say
Hinge Health Inc. faces a concerning trend in its financial metrics, as adjusted R&D expenditures are projected to decrease significantly from 23.7% of revenue in 3Q24 to 14.5% in 3Q25, indicating potential challenges in innovation and development. Furthermore, management's guidance expects mid-teens EBIT margins in the second half of 2025, which reflects a decline from the 19% margin reported in 2Q25 and suggests that FY26/FY27 consensus margins of 14.6% and 16.2% may be unsustainably low. Lastly, the anticipated decline in membership during the holiday season, coupled with reduced spending in sales and marketing, raises concerns about the company's ability to maintain revenue growth and profitability moving forward.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares